Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five ADRs Hedge Funds Are Bullish On: Baidu, Shire, JD.Com, More

Page 1 of 2

American depositary receipts -or ADRs- are U.S-traded negotiable certificates, which represent a specified number of shares (could be one or more) of a non-U.S-based company, which was established overseas. ADRs are issued by U.S banks or brokerages, which own the underlying securities abroad. While this could sound a bit elaborate, ADRs actually trade in the U.S like regular stocks, and help reduce the costs and risks of trading foreign equities.

Baidu Inc (ADR) (NASDAQ:BIDU), homepage, website, online, close up, magnifying glass

Gil C / Shutterstock.com

At Insider Monkey, we track around 765 hedge funds and institutional investors. In this article, we will take a look into the most popular ADRs among these firms going into the second quarter of 2016, based on the 13Fs they filed for the first quarter of the year. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

#5. NetEase Inc (ADR) (NASDAQ:NTES)

Fifth on our list is NetEase Inc (ADR) (NASDAQ:NTES), in which the number of hedge funds in our database long its shares surged by 24% during the first quarter of 2016, to 31. Their combined stakes accounted for roughly 21% of the outstanding ADRs of the company and were valued at more than $2.2 billion as of March 31. Among the funds that we track, the largest position was held by Jim Simons’ Renaissance Technologies, which disclosed ownership of 2.18 million ADRs of the company, worth over $314 million as of March 31. Also quite bullish was Panayotis Takis Sparaggis’ Alkeon Capital Management, which declared holding 988,650 ADRs.

NetEase Inc (ADR) (NASDAQ:NTES), which lost 20.78% of its value over the first three months of the year, has managed to recover most of those losses in the second quarter, largely driven by a top and bottom-line beat with its first quarter results released on May 11. The company reported first quarter EPS of RMB18.56 ($2.83) on revenue of RMB7.92 billion ($1.21 billion), beating the Street’s consensus estimates by RMB3.64 and RMB70 million, respectively. One particularly strong figure in the report was the company’s year-over-year revenue growth, which hit 116.4% on the back of strong mobile game sales. Another factor that helped the stock spike in late May was the reveal of a development slate of 41 games and a deal with Microsoft Corporation (NASDAQ:MSFT) to bring that company’s Minecraft to China.

Follow Netease Com Inc (NASDAQ:NTES)
Trade (NASDAQ:NTES) Now!

#4. Shire PLC (ADR) (NASDAQ:SHPG)

Next up is Shire PLC (ADR) (NASDAQ:SHPG), which counted the support of 49 funds among those we track as of the end of the first quarter, up by 22.5% quarter-over-quarter. Those stakes, valued at more than $2.5 billion on March 31, accounted for almost 1/3 of the company’s outstanding stock. Among the largest stockholders were John Paulson’s Paulson & Co, with 7.07 million shares worth over $1.2 billion, and Arrowstreet Capital. The latter fund, run by Peter Rathjens, Bruce Clarke and John Campbell, disclosed ownership of 526,768 ADRs of Shire PLC as of March 31.

As with many biotech stocks, Shire PLC (ADR) (NASDAQ:SHPG) suffered a rough first quarter, losing 16.15% of its value during the period. It has performed much better since April 1, having managed to rebound by 11.4%. Early Friday, the company announced that it had completed its merger with Baxalta Inc (NYSE:BXLT), creating a company with a presence in over 100 countries, more than 22,000 employees, and projected sales of more than $20 billion by 2020.

Follow Shire Plc
Trade (SHPGY) Now!

The three most popular ADRs among the funds that we track are revealed on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!